Medtronic (MDT) Tops Q3 EPS by 6c; Raises FY Outlook
Get Alerts MDT Hot Sheet
Revenue Growth %: -0.6%
Financial Fact:
Basic weighted average shares outstanding: 983.8M
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
(Updated - February 18, 2020 6:47 AM EST)
Medtronic (NYSE: MDT) reported Q3 EPS of $1.44, $0.06 better than the analyst estimate of $1.38. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.81 billion.
“Organic revenue growth was light this quarter, due largely to transient issues,” said Omar Ishrak, Medtronic chairman and chief executive officer. “However, we continue to feel very good about the fourth quarter, and in the third quarter, a softer top-line was more than offset by significant margin expansion, resulting in better-than-expected earnings per share and free cash flow.”
GUIDANCE:
Medtronic sees FY2020 EPS of $5.63-$5.65, versus the consensus of $5.60.
Medtronic sees Q4 EPS of $1.62-$1.64, versus the consensus of $1.64.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
- Torrid Holdings Inc. (CURV) Tops Q4 EPS by 4c, provides guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!